|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expense | |||||
| Research and development expense | |||||
| Amortization of acquired intangibles | |||||
| Gain (Loss) from Litigation Settlement | |||||
| Purchase of royalty interest | |||||
| Restructuring and other charges | |||||
| Goodwill impairment | |||||
| Operating loss | |||||
| Interest expense, net | |||||
| Debt extinguishment charges | |||||
| Equity Securities, FV-NI, Gain (Loss) | |||||
| Realized Investment Gains (Losses) | |||||
| Other (income) expense, net | |||||
| Loss from continuing operations before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss from continuing operations | |||||
| Income (loss) from discontinued operations, net of taxes | |||||
| Net loss | |||||
| Less: net income attributable to noncontrolling interest from continuing operations - net of taxes | |||||
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Noncontrolling Interest | |||||
| Net loss attributable to Enovis Corporation | |||||
| Earnings Per Share, Basic | |||||
| Continuing operations - basic (in usd per share) | |||||
| Discontinued operations - basic | |||||
| Consolidated operations - basic | |||||
| Earnings Per Share, Diluted | |||||
| Continuing operations - diluted (in usd per share) | |||||
| Discontinued operations - diluted | |||||
| Consolidated operations - diluted | |||||
Loading...
